Samyang Biopharm Corporation (KRX:0120G0)
South Korea · Delayed Price · Currency is KRW 91,700
+3,800 (4.32%)
Last updated: Mar 20, 2026, 11:51 AM KST
Samyang Biopharm Market Cap
Samyang Biopharm has a market cap or net worth of 653.61 billion as of March 19, 2026.
Market Cap
653.61B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
91,700.00
Market Cap Chart
Since November 24, 2025, Samyang Biopharm's market cap has increased from 224.56B to 653.61B, an increase of 191.06%. That is a compound annual growth rate of 2,869.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 653.61B | 67.43% |
| Dec 30, 2025 | 390.38B | 73.84% |
| Nov 24, 2025 | 224.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 1.43T |
| Myung In Pharmaceutical LTD. | 852.64B |
| ImmuneOncia Therapeutics | 630.40B |
| HEM Pharma | 517.80B |
| CellBion | 344.53B |
| DAE HWA Pharmaceutical | 257.32B |
| NOVAREX | 237.74B |
| GREEN CROSS WellBeing | 182.42B |